Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIRHISTAMI: Intensive vs Moderate Rosuvastatin in STEMI
NCT01203982Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Nov 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of rosuvastatin in ST-segment elevation myocardial infarction (STEMI) and carotid atheroma (CAS) (2 arms), sponsored by University Hospital Odense. Primary endpoint: Change from baseline in mean Carotid Intima-Media Thickness at 12 months. Started Nov 2007; status: completed.
02
Drugs
rosuvastatin
03
Conditions
ST-segment elevation myocardial infarction (STEMI)carotid atheroma (CAS)
Beyond the preview
Go deeper on NCT01203982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01203982.